Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CM Life Sciences
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
CM Life Sciences SPACs have successfully raised capital, led by Casdin Capital and Corvex Management, and merged with several advanced life science and health tech companies (notably Sema4 – clinical genomics/data platforms; SomaLogic – proteomics platform).
- Modalities
- Small moleculeMonoclonal antibodyDiagnostic platformsSynthetic biology
- Industry
- Investors
Beyond the preview
Go deeper on CM Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CM Life Sciences.